BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26801879)

  • 1. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
    Miura Y; Endo T
    Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the absolute quantification of N-glycan biomarkers.
    Etxebarria J; Reichardt NC
    Biochim Biophys Acta; 2016 Aug; 1860(8):1676-87. PubMed ID: 26953846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of protein glycosylation for personalised medicine.
    Almeida A; Kolarich D
    Biochim Biophys Acta; 2016 Aug; 1860(8):1583-95. PubMed ID: 26987810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
    Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
    Schumacher KN; Dodds ED
    Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics.
    Miura Y; Hashii N; Ohta Y; Itakura Y; Tsumoto H; Suzuki J; Takakura D; Abe Y; Arai Y; Toyoda M; Kawasaki N; Hirose N; Endo T
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1462-1471. PubMed ID: 29580922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.
    Hennig R; Cajic S; Borowiak M; Hoffmann M; Kottler R; Reichl U; Rapp E
    Biochim Biophys Acta; 2016 Aug; 1860(8):1728-38. PubMed ID: 27038647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation Analysis on Postgenomic Biomarkers: Glycomics for Chronic Diseases.
    Adua E; Russell A; Roberts P; Wang Y; Song M; Wang W
    OMICS; 2017 Apr; 21(4):183-196. PubMed ID: 28388299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycomic and glycoproteomic analysis of glycoproteins-a tutorial.
    Shajahan A; Heiss C; Ishihara M; Azadi P
    Anal Bioanal Chem; 2017 Jul; 409(19):4483-4505. PubMed ID: 28585084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations.
    Campbell MP; Packer NH
    Biochim Biophys Acta; 2016 Aug; 1860(8):1669-75. PubMed ID: 26940363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers.
    Ueda K
    Proteomics Clin Appl; 2013 Oct; 7(9-10):607-17. PubMed ID: 23640819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automating mass spectrometry-based quantitative glycomics using aminoxy tandem mass tag reagents with SimGlycan.
    Meitei NS; Apte A; Snovida SI; Rogers JC; Saba J
    J Proteomics; 2015 Sep; 127(Pt A):211-22. PubMed ID: 26003531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics protocols in glycomics and glycoproteomics.
    Tang H; Mayampurath A; Yu CY; Mechref Y
    Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycobiomarkers by glycoproteomics and glycan profiling (glycomics): emergence of functionality.
    Gabius HJ
    Biochem Soc Trans; 2011 Jan; 39(1):399-405. PubMed ID: 21265812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycomic biomarkers of biological aging and longevity: a link with inflammaging.
    Dall'Olio F; Vanhooren V; Chen CC; Slagboom PE; Wuhrer M; Franceschi C
    Ageing Res Rev; 2013 Mar; 12(2):685-98. PubMed ID: 22353383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
    Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
    Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 2.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Apr; 15(4):341-352. PubMed ID: 29521143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro analysis to map the glycome code.
    Simone G
    Proteomics; 2014 May; 14(9):994-1000. PubMed ID: 24596138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.